Anika Therapeutics reported $363.13M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Agenus AGEN:US $ 192.3M 42.62M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Anika Therapeutics ANIK:US $ 363.13M 0.88M
Arrowhead Research ARWR:US $ 734.93M 21.87M
Chemocentryx CCXI:US $ 467.67M 31.44M
Clovis Oncology CLVS:US $ 572.23M 23.39M
Dicerna Pharmaceuticals DRNA:US $ 838.49M 155.08M
Enanta Pharmaceuticals ENTA:US $ 450.44M 17.33M
Flexion Therapeutics FLXN:US $ 210.05M 20.33M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Immunogen IMGN:US $ 301.45M 44.52M
Insmed INSM:US $ 1.23B 537.39M
Intrexon XON:US $ 402.57M 4.41M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Ligand Pharmaceuticals LGND:US $ 1256.28M 38.84M
Macrogenics MGNX:US $ 425.91M 9.53M
Merit Medical Systems MMSI:US $ 1642.39M 9.33M
Peregrine Pharmaceuticals PPHM:US $ 270.53M 5.02M
Rigel Pharmaceuticals RIGL:US $ 201.6M 14.4M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Stryker SYK:US $ 33698M 243M
Surmodics SRDX:US $ 177.2M 0.1M
Veracyte VCYT:US $ 1027.44M 2.3M
Xencor XNCR:US $ 695.6M 2.86M
Zimmer Biomet Holdings Inc ZBH:US $ 24.22B 196.6M